Latest Breaking News On - Preclinical development at eurocine vaccines - Page 1 : comparemela.com

Eurocine Vaccines confirms good immunological effect in preclinical study with the chlamydia vaccine candidate Eurocine Vaccines AB ( Eurocine Vaccines ) confirms good immunological effect in a preclinical animal study with its chlamydia vaccine candidate. The study confirms that an adapted variant of the vaccine, designed to meet the regulatory requirements for a finished product, is highly immunogenic. The good immunological effect of the tested vaccine surpasses, by a good margin, what in previous studies with our vaccine has provided protection in preclinical models. STOCKHOLM, Sweden, Feb. 25, 2021 /PRNewswire/ In the current study, a chlamydia vaccine candidate, adapted to meet regulatory requirements, has been evaluated. The study shows that Eurocine Vaccines chlamydia vaccine candidate, after adaptation, remains highly immunogenic and focuses the immune response to the relevant parts of the chlamydia bacterium. The antibodies that the vaccine induces bind to the same par

United kingdomCity ofKostenloser wertpapierhandelHans arwidssonKarl ljungbergPreclinical development at eurocine vaccinesGlobe life sciences ltdEurocine vaccinesEurocine vaccinePreclinical developmentGlobe life sciencesஒன்றுபட்டது கிஂக்டம்நகரம் ஆஃப்பூகோளம் வாழ்க்கை அறிவியல் லிமிடெட்பூகோளம் வாழ்க்கை அறிவியல்தடுப்பு மருந்துகள்